JoAnn Lindenfeld

Employment

• Vanderbilt University Medical Center Professor
  2015 - Present
• Vanderbilt University Medical Center

Education

• Vanderbilt University Medical Center

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Utility of Donor-Recipient HLA Matching in Heart Transplantation in the Era of Extended Donor Organ Preservation: A Multi-Institutional Analysis
  The Journal of Heart and Lung Transplantation 2026 DOI: 10.1016/j.healun.2026.10.026
  +Save
• Modeling Individual Patient Outcomes After Interatrial Shunt Treatment in Heart Failure With Reduced and Preserved Ejection Fraction: The RELIEVE-HF Trial
  Gregg W. Stone, JoAnn M. Lindenfeld, Michael R. Zile +17 more
  Circulation: Heart Failure 2026 DOI: 10.1161/CIRCHEARTFAILURE.125.014100
  +Save
• Association of Novel Ventricular Assist Device Self-report Measures With Overall Health-Related Quality of Life
  Journal of Cardiovascular Nursing 2025 DOI: 10.1097/JCN.0000000000001129
  +Save
• Impact of Natriuretic Peptide and Prior Hospitalization in Patients With Severe Mitral Regurgitation: COAPT Trial
  Circulation: Cardiovascular Interventions 2025 DOI: 10.1161/CIRCINTERVENTIONS.125.015192
  +Save
• Therapeutic left-to-right shunting in heart failure
  European Heart Journal 2025 DOI: 10.1093/eurheartj/ehaf120
  +Save
• Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial
  Gregg W. Stone, JoAnn M. Lindenfeld, Josep Rodés‐Cabau +97 more
  Circulation 2024 DOI: 10.1161/CIRCULATIONAHA.124.070870
  +Save
• Efficient measurement of multiple ventricular assist device patient-reported outcomes: Creation of a 20-item profile from the MCS A-QOL study
  The Journal of Heart and Lung Transplantation 2024 DOI: 10.1016/j.healun.2024.04.060
  +Save
• Regurgitant volume to LA volume ratio in patients with secondary MR: the COAPT trial
  European Heart Journal - Cardiovascular Imaging 2024 DOI: 10.1093/ehjci/jead328
  +Save
• Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial
  Journal of the American Heart Association 2024 DOI: 10.1161/JAHA.123.031796
  +Save
• In Cardiogenic Shock, Age is Not Just a Number
  Cardiac Failure Review 2024 DOI: 10.15420/cfr.2023.22
  +Save
• Extracorporeal Life Support for Cardiogenic Shock in Adult Congenital Heart Disease—An ELSO Registry Analysis
  ASAIO Journal 2023 DOI: 10.1097/MAT.0000000000002026
  +Save
• Clonal hematopoiesis of indeterminate potential and outcomes after heart transplantation: A multicenter study
  American Journal of Transplantation 2023 DOI: 10.1016/j.ajt.2023.04.028
  +Save
• Enhanced Thrombin Formation in Patients With Ventricular Assist Devices Experiencing Bleeding: Insights From the Multicenter PREVENT Study
  ASAIO Journal 2023 DOI: 10.1097/MAT.0000000000001790
  +Save
• Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial
  Journal of the American Heart Association 2023 DOI: 10.1161/JAHA.122.028444
  +Save
• In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction
  Cardiac Failure Review 2022 DOI: 10.15420/cfr.2022.08
  +Save
• Extracorporeal Membrane Oxygenation as a Treatment for Branch Pulmonary Artery Rupture Following Right Heart Catheterisation
  Cardiac Failure Review 2022 DOI: 10.15420/cfr.2021.25
  +Save
• Chest Pain in a Psychiatric Patient Due to Clozapine-Induced Myopericarditis
  Case Reports in Cardiology 2021 DOI: 10.1155/2021/6067652
  +Save